UBS' Bottom Quant Stocks In AI, IT, Healthcare & Others: 29 Stocks In All Sectors
With November 2024 having settled in and the US presidential election in its final stages, investors are also digesting the results of the latest earnings season.
West Pharmaceutical Services Inc (WST)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Durable Capital Partners Henry Ellenbogen | 1,085,919 | $325,949,447 | +5% | 2.38% |
| 2. | Adage Capital Management Phill Gross And Robert Atchinson | 178,407 | $53,550,645 | +6% | 0.09% |
| 3. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 167,750 | $50,351,840 | +16% | 1.63% |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 128,259 | $38,498,222 | +168% | 0.04% |
| 5. | Holocene Advisors Brandon Haley | 109,440 | $32,849,510 | -42% | 0.13% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $105.14 | 54 | 66,251 | 2019-02-28 | Filing | ||
| $110.55 | 57 | 66,197 | 2018-07-31 | Filing | ||
| $93.94 | 335 | 66,475 | 2017-10-17 | Filing | ||
| $88.89 | 275 | 56,540 | 2018-05-15 | Filing | ||
| $84.53 | 332 | 51,831 | 2016-12-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $310.40 | 225 | Officer | 1,253 | 2024-10-29 | Filing | |
| $310.40 | 478 | Officer | 1,478 | 2024-10-29 | Filing | |
| $300.00 | 500 | Officer | 1,478 | 2024-08-19 | Filing | |
| $300.00 | 529 | Officer | 1,978 | 2024-08-19 | Filing | |
| $365.92 | 617 | Director | 43,565 | 2024-05-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,002,632 | $3,170,006,779 | 0.06% | |
| 2. | 7,778,305 | $2,738,896,586 | 0.06% | |
| 3. | 3,331,553 | $1,173,106,497 | 0.23% | |
| 4. | 3,271,929 | $1,152,111,639 | 0.05% | |
| 5. | 2,105,589 | $741,420,002 | 0.34% |
News See All
West Pharmaceutical Services (WST) Fell Due to Lower-Than-Expected Results and Reduced Guidance
Baron Funds, an investment management company, released its “Baron Asset Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2024 Earnings Call Transcript October 24, 2024West Pharmaceutical Services, Inc. beats earnings expectations.
West Pharmaceuticals (WST) Fell Due to Industry Headwinds
Conestoga Capital Advisors, an asset management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Should You Hold West Pharmaceutical Services (WST) for the Long Term?
Conestoga Capital Advisors, an asset management company, released its “Mid-Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2024 Earnings Call Transcript July 25, 2024West Pharmaceutical Services, Inc. misses on earnings expectations.
Does West Pharmaceutical Services (WST) Have Attractive Growth Drivers?
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
25 Best Dividend Aristocrats to Buy According to Analysts
The age-old debate of investing in dividend growth or high-yield stocks continues to reappear within the dividend investing realm.
Here’s Why West Pharmaceutical Services (WST) Bounced Back in Q1
Conestoga Capital Advisors, an asset management company, released its “Mid-Cap Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. beats earnings expectations. Reported EPS is $1.56, expectations were $1.26. West Pharmaceutical Services, Inc.
Billionaire Hedge Funds
